Recently, whole‐exon sequencing of five paired hepatitis B virus‐associated early‐stage HCC samples found that DNAH17 was frequently mutated in HCC patients.17 The data from the Cancer Genome Atlas (TCGA) dataset confirmed the conclusion that genetic alteration of DNAH17 was common. This evidence concerns the gene DNAH17 and hepatocellular carcinoma.